Literature DB >> 1372606

Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype.

Y Sugimoto1, T Namba, A Honda, Y Hayashi, M Negishi, A Ichikawa, S Narumiya.   

Abstract

A functional cDNA clone for mouse EP3 subtype of prostaglandin (PG) E receptor was isolated from a mouse cDNA library using polymerase chain reaction based on the sequence of the human thromboxane A2 receptor and cross-hybridization screening. The mouse EP3 receptor consists of 365 amino acid residues with putative seven-transmembrane domains. The sequence revealed significant homology to the human thromboxane A2 receptor. Ligand binding studies using membranes of COS cells transfected with the cDNA revealed specific [3H]PGE2 binding. The binding was displaced with unlabeled PGs in the order of PGE2 = PGE1 greater than iloprost greater than PGF2 alpha greater than PGD2. The EP3-selective agonists, M&B 28,767 or GR 63799X, potently competed for the [3H]PGE2 binding, but no competition was found with EP1- or EP2-selective ligands. PGE2 and M&B 28,767 decreased forskolin-induced cAMP formation in a concentration-dependent manner in Chinese hamster ovary cells permanently expressing the cDNA. Northern blot analysis demonstrated that the EP3 mRNA is expressed abundantly in kidney, uterus, and mastocytoma P-815 cells and in a lesser amount in brain, thymus, lung, heart, stomach, and spleen.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372606

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1.

Authors:  A Ericsson; C Arias; P E Sawchenko
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

Review 2.  Role of heterotrimeric G proteins in membrane traffic.

Authors:  M Bomsel; K Mostov
Journal:  Mol Biol Cell       Date:  1992-12       Impact factor: 4.138

3.  Prostaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells.

Authors:  Shun-Fa Yang; Mu-Kuan Chen; Yih-Shou Hsieh; Tsung-Te Chung; Yi-Hsien Hsieh; Chiao-Wen Lin; Jen-Liang Su; Ming-Hsui Tsai; Chih-Hsin Tang
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

4.  Molecular Architecture of G Protein-Coupled Receptors.

Authors:  A Michiel van Rhee; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1996-01-01       Impact factor: 4.360

5.  Prostaglandin E2 inhibits platelet-derived growth factor-stimulated cell proliferation through a prostaglandin E receptor EP2 subtype in rat hepatic stellate cells.

Authors:  Shigeki Koide; Yoshimasa Kobayashi; Yutaka Oki; Hirotoshi Nakamura
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

6.  Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.

Authors:  Milena Sokolowska; Li-Yuan Chen; Yueqin Liu; Asuncion Martinez-Anton; Hai-Yan Qi; Carolea Logun; Sara Alsaaty; Yong Hwan Park; Daniel L Kastner; Jae Jin Chae; James H Shelhamer
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

7.  Ontogenic increase in PGE2 and PGF2 alpha receptor density in brain microvessels of pigs.

Authors:  D Y Li; D R Varma; S Chemtob
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

8.  Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.

Authors:  S J Lydford; K McKechnie
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

9.  Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development.

Authors:  Y Shoji; M Takahashi; T Kitamura; K Watanabe; T Kawamori; T Maruyama; Y Sugimoto; M Negishi; S Narumiya; T Sugimura; K Wakabayashi
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

10.  Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts.

Authors:  S Harada; J A Nagy; K A Sullivan; K A Thomas; N Endo; G A Rodan; S B Rodan
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.